Discover open access scientific publications

Search, annotate, share and cite publications

Publications by N Kentepozidis

Second-Line Pazopanib in Patients With Relapsed and Refractory Small-Cell Lung Cancer: A Multicentre Phase II Study of the Hellenic Oncology Research Group

British Journal of Cancer

Cancer Research

Oncology

2017

English

Related publications

Nab-Paclitaxel as Second-Line Treatment in Advanced Gastric Cancer: A Multicenter Phase II Study of the Hellenic Oncology Research Group

Annals of Gastroenterology

2017

English

Single Agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study

Research in Oncology

2007

English

Pazopanib Maintenance After First-Line Etoposide and Platinum Chemotherapy in Patients With Extensive Disease Small-Cell Lung Cancer: A Multicentre, Randomised, Placebo-Controlled Phase II Study (KCSG-LU12-07)

British Journal of Cancer

Cancer Research

Oncology

2018

English

Phase II Study of Intermediate-Dose Cytarabine in Patients With Relapsed or Refractory Ewing Sarcoma: A Report From the Children's Oncology Group

Pediatric Blood and Cancer

English

Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)

Journal of Thoracic Oncology

English

Phase II Trial of Temozolomide in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer, With Assessment of Methylguanine-Dna Methyltransferase as a Potential Biomarker

Clinical Cancer Research

Cancer Research

Oncology

2012

English

P2.12-05 SUKSES (Small Cell Lung Cancer Umbrella Korea Studies): A Phase II Biomarker-Driven Umbrella Study in Relapsed or Refractory SCLC

Journal of Thoracic Oncology

English

A Phase II Study of Oral Etoposide in Elderly Patients With Small Cell Lung Cancer.

English

A Phase II Study of Docetaxel in Patients With Relapsed and Refractory Ewing's Tumours

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by N Kentepozidis

Second-Line Pazopanib in Patients With Relapsed and Refractory Small-Cell Lung Cancer: A Multicentre Phase II Study of the Hellenic Oncology Research Group

Related publications

Nab-Paclitaxel as Second-Line Treatment in Advanced Gastric Cancer: A Multicenter Phase II Study of the Hellenic Oncology Research Group

Single Agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study

Pazopanib Maintenance After First-Line Etoposide and Platinum Chemotherapy in Patients With Extensive Disease Small-Cell Lung Cancer: A Multicentre, Randomised, Placebo-Controlled Phase II Study (KCSG-LU12-07)

Phase II Study of Intermediate-Dose Cytarabine in Patients With Relapsed or Refractory Ewing Sarcoma: A Report From the Children's Oncology Group

Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)

Phase II Trial of Temozolomide in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer, With Assessment of Methylguanine-Dna Methyltransferase as a Potential Biomarker

P2.12-05 SUKSES (Small Cell Lung Cancer Umbrella Korea Studies): A Phase II Biomarker-Driven Umbrella Study in Relapsed or Refractory SCLC

A Phase II Study of Oral Etoposide in Elderly Patients With Small Cell Lung Cancer.

A Phase II Study of Docetaxel in Patients With Relapsed and Refractory Ewing's Tumours